Cuize Medicine

Hangzhou, China · Founded 2019 · Privately Held (backing)

Developer of pulmonary therapy medication intended to be used for the perioperative period. Cuize Medicine is based in Hangzhou, China and was founded in 2019. Its last reported valuation was $83.4 million in Jun 2025. It has raised $12.6 million.

Last reported valuation

$83.4M

Oct 2026

Priced at

—

Total raised

$12.6M

Last round

—

How much has Cuize Medicine raised?

$12.6Macross 0 recorded rounds

Free account

More of Cuize Medicine with a free account

·Watch Cuize Medicine: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Cuize Medicine investors

3 investors are on record for Cuize Medicine, including Goldport Capital, Jiangguo Investment Management and Zhejiang Xianju Pharmaceutical Company.

For fundraisers

Raising for a company like Cuize Medicine?

3 investors have backed Cuize Medicine.

See all 3 investors →

Frequently asked about Cuize Medicine

How much has Cuize Medicine raised?: Cuize Medicine has raised $12.6M in total across 0 recorded funding rounds.